Skip to main content

Financial News

  • Rite Aid adds social, mobile elements to 18th annual Miracle Balloon campaign

    CAMP HILL, Pa. — Rite Aid is set to launch its annual fundraising campaign designed to benefit an organization of 170 children's hospitals throughout North America.

    Rite Aid said it will kick off its 18th annual Miracle Balloon campaign in support of Children's Miracle Network Hospitals this Sunday. Through May 19, customers who purchase a $1 Miracle Balloon at any Rite Aid will receive $7 in coupon offers good for a variety of items sold at Rite Aid.

  • Family Dollar: Net income, EPS see double-digit growth in Q2

    MATTHEWS, N.C. — Rising gas prices and a cautious consumer environment continues to benefit the dollar store, with Family Dollar being the latest example. The company reported that net income for the second quarter of fiscal year 2012, ended Feb. 25, increased 10.7% to $136.4 million, compared with net income of $123.2 million for the second quarter of fiscal year 2011. Net income per diluted share for the quarter increased 17.3% to $1.15, compared with 98 cents for the same period last year.

  • Walgreens confident in Q2 results following Express Scripts exit Jan. 1

    DEERFIELD, Ill. — On the eve of a potential Federal Trade Commission approval of the Express Scripts-Medco merger, Walgreens' underlying fundamentals still are strong, Walgreens president and CEO Greg Wasson told analysts Tuesday morning. It's that underlying strength that has helped Walgreens in the wake of its exit from the Express Scripts pharmacy benefit network, a factor that impacted Walgreens' net earnings by 7 cents per diluted share for its second quarter ended Feb. 29.

  • Bausch + Lomb agrees to buy Ista

    MADISON, N.J., and IRVINE, Calif. — Bausch + Lomb will acquire eye drug maker Ista Pharmaceuticals for $9.10 per share in cash, or approximately $500 million.

  • Increase in Rx costs surpasses inflation rate

    Increases in the prices of prescription drugs have far outpaced the rate of general inflation over the years, as increases in the prices of branded and specialty drugs have offset decreases in the prices of generics, according to a new report by AARP’s research arm.


    The study, conducted by AARP’s Public Policy Institute, found that the cumulative change in drug prices from 2005 to 2009 was almost double the rate of inflation. As a result, the average annual cost of drug therapy continued to rise.


  • McKesson completes Katz Group Canada pharmacy acquisition

    SAN FRANCISCO — McKesson on Monday announced that it has completed the previously announced acquisition of the independent banner and franchise businesses of Katz Group Canada in an all-cash transaction that closed March 25.

  • Prestige maintains momentum

    U.S. prestige beauty posted its highest sales results in 15 years, with all beauty categories surpassing pre-recession levels, according to market research firm NPD Group. According to NPD’s beauty market research, total U.S. prestige beauty generated $9.5 billion in 2011, an increase of 11% in dollars. This compares with $8.6 billion in 2010.


  • Vitamin shoppers spend more across HBA

    According to analysis by Pharmavite, vitamin-buying households spend more than other category buyers across the health and beauty department with regard to average dollars spent per item per occasion. Vitamin buyers spend $14.95 per item per occasion, versus $14.54 for the next highest category (women’s fragrance) and $12.11 for shoppers buying diet aids.


X
This ad will auto-close in 10 seconds